Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2024-11-28EMA Authorised: Xultophy (insulin degludec;liraglutide) — Novo Nordisk A/S
The European Medicines Agency authorised Xultophy, a fixed-dose combination of insulin degludec and liraglutide, for adults with type 2 diab…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release
This clinical trial update reports real-world effectiveness and patient insights when adding a sodium-glucose cotransporter 2 (SGLT2) inhibi…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Time Restricted Eating for the Treatment of Type 2 Diabetes [NA]
A completed clinical trial from the University of Illinois at Chicago evaluates time-restricted eating as a treatment for Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES)
A real-world study assessing the efficacy of the Insulia dosing tool for patients with type 2 diabetes on basal insulin within France's ETAP…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Evaluation of Chlorhexidine Gel Associated with Photodynamic Therapy in the Treatment of Chronic Periodontitis in Type 2 Diabetics [NA]
The clinical trial evaluating chlorhexidine gel used with photodynamic therapy for chronic periodontitis in adults with type 2 diabetes has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population
A clinical trial aims to classify adult-onset diabetes into five subgroups in the Pakistani population. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Observational Cohort Study Evaluating the Effectiveness of an Education Program (NGAYDAUTIEN) in Combination With Gliclazide MR in the Management of Uncontrolled Type 2 Diabetic Patients.
This document reports the completion of an observational cohort study evaluating the effectiveness of an education program combined with gli…
-
FDA approval · 2024-11-25FDA Approved: INSULIN GLARGINE — Supplemental Application (Biocon Biologics Inc.)
FDA approved a supplemental application for INSULIN GLARGINE-YFGN from Biocon Biologics Inc., authorizing its biosimilar insulin glargine pr…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients [Phase 2]
This Phase 2 trial update reports results from switching Type 2 diabetes patients from a daily DPP-4 inhibitor to HSK7653.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients [NA]
A completed clinical trial evaluated photobiomodulation for treating xerostomia in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: The Healthy Eating with APP TechnologY Study [NA]
Clinical trial update noting the completion of the Healthy Eating with APP Technology Study by Karolinska Institutet, examining Type 2 Diabe…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Mastering Diabetes Study [NA]
This update provides the status of the Mastering Diabetes Study (NCT04454957) sponsored by Ohio University. The trial targets type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Liver Fibrosis Assessment in Diabetic Patients [NA]
A clinical trial at National Taiwan University Hospital is assessing liver fibrosis in patients with Type 2 diabetes and metabolic dysfuncti…
-
EMA approval · 2024-11-21EMA Authorised: Bydureon (exenatide) — AstraZeneca AB
The European Medicines Agency authorised Bydureon (exenatide extended-release) for type 2 diabetes mellitus, with AstraZeneca AB as the mark…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes. [NA]
A completed clinical trial evaluated how increasing the restrictive factor of the One Anastomosis Gastric Bypass affects metabolic outcomes …
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD [Phase 2]
A Phase 2 clinical trial update for REDUCE-PAD evaluating strategies to reduce macrovascular complications in adults with type 2 diabetes an…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM) [NA]
A clinical trial registry entry for the CATCH-EM study evaluating empagliflozin's impact on myocardial blood flow in asymptomatic adults wit…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease [NA]
This Clinical Trial Update reports that a 12-month site-randomized study in adults with type 2 diabetes mellitus and a history of cardiovasc…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan [NA]
A completed clinical trial evaluated the role of a clinical pharmacist in managing Type 2 diabetes patients in a primary medical center in J…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Effect of Ertugliflozin on Cardiac Function in Diabetes [Phase 3]
Phase 3 trial evaluating ertugliflozin on cardiac function in adults with type 2 diabetes; the study completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Carbohydrate Quality and Its Impact on Sleep and Depression in Type 2 Diabetes
A clinical trial from Ankara Yildirim Beyazıt University studying the effects of carbohydrate quality on sleep and depression in individuals…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
A clinical trial investigating the impact of pharmacist-led collaborative practice on outcomes in people with diabetes. The study is current…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Dietary Approaches to Stop Hypertension for Diabetes [NA]
This is a completed clinical trial update for the DASH for Diabetes study. It examines dietary approaches to control hypertension in people …
-
FDA approval · 2024-11-19FDA Approved: EXENATIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's original application for a generic version of exenatide for adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors
A post-authorisation safety study comparing empagliflozin with DPP-4 inhibitors in adults with type 2 diabetes reports results on risks incl…